benzimidazole has been researched along with paclitaxel in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, S; Li, Z; Meng, X; Pan, L; Su, B; Yang, S; Yu, S; Zhang, C; Zhong, B | 1 |
Chen, Z; Deng, G; Gong, L; Gong, Y; Li, Y; Wang, J; Wu, D; Yang, X; Zhang, H; Zhou, B | 1 |
Buscemi, G; Carlessi, L; Delia, D; Hong, Z; Larson, G; Wu, JZ | 1 |
3 other study(ies) available for benzimidazole and paclitaxel
Article | Year |
---|---|
Synthesis and biological evaluation of thiabendazole derivatives as anti-angiogenesis and vascular disrupting agents.
Topics: Angiogenesis Inhibitors; Anthelmintics; Cell Proliferation; Drug Repositioning; HCT116 Cells; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Structure-Activity Relationship; Thiabendazole; Tubulin; Tubulin Modulators | 2015 |
Synthesis and antitumor activity of novel steroidal imidazolium salt derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Molecular Structure; Salts; Steroids; Structure-Activity Relationship | 2019 |
Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.
Topics: Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Benzimidazoles; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cell Proliferation; Cells, Cultured; Checkpoint Kinase 1; Checkpoint Kinase 2; Cisplatin; DNA Damage; DNA-Binding Proteins; Doxorubicin; Enzyme Inhibitors; Humans; Immunoprecipitation; Mice; Molecular Structure; Paclitaxel; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Radiation, Ionizing; Recombinant Proteins; Serine; Thiazoles; Threonine; Tumor Suppressor Proteins | 2007 |